Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-07-12 Purchase(A) |
2021-07-15 9:44 pm |
Alzamend Neuro Inc. | ALZN | AULT MILTON C III 10% Owner |
14,500 | $6.1473 | $89,136 | 30,320,555 (Indirect) |
View |
| 2021-07-12 Purchase |
2021-07-14 6:34 pm |
Alzamend Neuro Inc. | ALZN | AULT MILTON C III 10% Owner |
14,000 | $6.3668 | $89,136 | 30,320,055 (Indirect) |
View |
| 2021-07-06 Purchase |
2021-07-08 7:36 pm |
Alzamend Neuro Inc. | ALZN | AULT MILTON C III 10% Owner |
14,000 | $6.6507 | $93,109 | 30,306,055 (Indirect) |
View |
| 2021-07-01 Purchase |
2021-07-02 6:43 pm |
Alzamend Neuro Inc. | ALZN | AULT MILTON C III 10% Owner |
26,000 | $7.5254 | $195,661 | 30,292,055 (Indirect) |
View |
| 2021-06-25 Purchase |
2021-06-29 8:44 pm |
Alzamend Neuro Inc. | ALZN | AULT MILTON C III 10% Owner |
24,300 | $9.1498 | $222,339 | 30,266,055 (Indirect) |
View |
| 2021-06-29 Sale |
2021-06-29 8:44 pm |
Alzamend Neuro Inc. | ALZN | AULT MILTON C III 10% Owner |
300 | $10.06 | $3,018 | 30,266,055 (Indirect) |
View |
| 2021-06-23 Purchase |
2021-06-25 6:53 pm |
Alzamend Neuro Inc. | ALZN | AULT MILTON C III 10% Owner |
12,000 | $8.39 | $100,680 | 30,242,055 (Indirect) |
View |
| 2021-06-15 Purchase |
2021-06-22 6:02 pm |
Alzamend Neuro Inc. | ALZN | AULT MILTON C III 10% Owner |
74,000 | $9.2854 | $687,117 | 30,230,055 (Indirect) |
View |
| 2021-06-17 Sale |
2021-06-22 6:02 pm |
Alzamend Neuro Inc. | ALZN | AULT MILTON C III 10% Owner |
1,000 | $10.16 | $10,160 | 30,230,055 (Indirect) |
View |
| 2021-06-15 Purchase |
2021-06-17 4:31 pm |
Alzamend Neuro Inc. | ALZN | AULT MILTON C III 10% Owner |
2,000,000 | $5 | $10,000,000 | 25,000,000 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-15 Option Award |
2021-07-16 5:00 pm |
N/A 2024-09-13 |
Alzamend Neuro Inc. | ALZN | Oram Jeffrey Director |
400,000 | $0 | 400,000 (Direct) |
View |
Ownership |
2021-06-21 11:59 am |
N/A N/A |
Alzamend Neuro Inc. | ALZN | Woo Andrew H. Director |
0 | $0 | 0 (Direct) |
View |
| 2021-06-17 Conversion |
2021-06-17 4:31 pm |
N/A N/A |
Alzamend Neuro Inc. | ALZN | AULT MILTON C III 10% Owner |
15,750,000 | $0 | 25,000,000 (Indirect) |
View |
Ownership |
2021-06-14 7:55 pm |
N/A 2026-04-29 |
Alzamend Neuro Inc. | ALZN | Horne William B. Director |
0 | $0 | 3,000,000 (Direct) |
View |
Ownership |
2021-06-14 7:55 pm |
N/A N/A |
Alzamend Neuro Inc. | ALZN | Lien Escalona Chief Financial Officer |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-06-14 7:55 pm |
N/A 2029-11-18 |
Alzamend Neuro Inc. | ALZN | Jackman Stephan Chief Executive Officer |
0 | $0 | 7,000,000 (Direct) |
View |
Ownership |
2021-06-14 7:55 pm |
N/A N/A |
Alzamend Neuro Inc. | ALZN | AULT MILTON C III 10% Owner |
0 | $0 | 36,944,555 (Indirect) |
View |
Ownership |
2021-06-14 7:55 pm |
N/A N/A |
Alzamend Neuro Inc. | ALZN | Katzoff David J Chief Operating Officer |
0 | $0 | 2,527,000 (Direct) |
View |
Ownership |
2021-06-14 7:55 pm |
N/A 2024-04-30 |
Alzamend Neuro Inc. | ALZN | Nisser Henry Carl Exec VP and General Counsel |
0 | $0 | 1,250,000 (Direct) |
View |
Ownership |
2021-06-14 7:55 pm |
N/A 2028-12-14 |
Alzamend Neuro Inc. | ALZN | CRAGUN KENNETH S SVP of Finance |
0 | $0 | 2,500,000 (Direct) |
View |